Differences in cancer incidence by age at diagnosis between Aboriginal and non-Aboriginal people for cancer types included in Australian national screening programs |
| |
| Affiliation: | 1. Cancer Institute NSW, GPO Box 41, Alexandria, Sydney NSW 1435, Australia;2. School of Public Health and Community Medicine, University of New South Wales, UNSW Sydney 2052, Australia;3. School of Health Sciences, Cancer Epidemiology and Population Health, University of South Australia, GPO Box 2471, Adelaide SA 5001, Australia;1. Moffitt Cancer Center, Department of Health Outcomes and Behavior, 4115 E. Fowler Ave., Tampa, FL 33617, United States;2. Moffitt Cancer Center, Center for Immunization and Infection Research in Cancer, 12902 USF Magnolia Drive, Tampa, FL 33612, United States;3. Moffitt Cancer Center, Department of Cancer Epidemiology, 12902 USF Magnolia Drive, Tampa, FL 33612, United States;4. Moffitt Cancer Center, Department of Biostatistics and Bioinformatics, 12902 USF Magnolia Drive, Tampa, FL 33612, United States;5. University of South Florida, Department of Family Medicine, 13330 USF Laurel Drive, Tampa, FL 33612, United States;6. University of South Florida, Department of Epidemiology & Biostatistics, 13201 Bruce B Downs Blvd, Tampa, FL 33612, United States;8. University of Florida, Department of Medicine, 1600 SW Archer Rd., Gainesville, FL 32608, United States;9. University of Florida Health, Department of Health Outcomes and Biomedical Informatics, 2004 Mowry Road, Ste 2245, Gainesville, FL 32610, United States;10. University of Florida Health, Cancer Population Sciences, 2004 Mowry Road, Ste 2245, Gainesville, FL 32610, United States;1. Department of Medical Sciences, Section of Dermatology and Infectious Diseases, University of Ferrara, Ferrara, Italy;2. Piacenza Cancer Registry, Local Health Unit, Piacenza, Italy;3. Parma Cancer Registry, University Hospital of Parma, Parma, Italy;4. Reggio Emilia Cancer Registry, Epidemiology Unit, Local Health Unit-IRCCS Reggio Emilia, Reggio Emilia, Italy;5. Modena Cancer Registry, Public Health Department, Local Health Unit Modena, Modena, Italy;6. Romagna Cancer Registry, Romagna Cancer Institute, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRST, IRCCS, Meldola, Forlì, Italy;7. Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy;8. Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Local Health Authority Ferrara, Ferrara, Italy;1. Epidemiology Section, Public Health Division, Department of Health of Madrid, C/San Martín de Porres, 6, 28035, Madrid, Spain;2. CIBER of Epidemiology and Public Health (CIBERESP), Avenida Monforte de Lemos, 3-5, Pabellón 11, Planta 0, 28029, Madrid, Spain;3. National Center of Epidemiology, Carlos III Health Institute, Avenida Monforte de Lemos, 5, 28029, Madrid, Spain;4. Infections and Cancer Epidemiology, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany;5. Department of Microbiology, Hospital Universitario Ramón y Cajal and Ramón y Cajal Health Research Institute (IRYCIS), Carretera de Colmenar Viejo, km. 9,100, 28034, Madrid, Spain;6. Department of Preventive Medicine and Public Health, Hospital Universitario Rey Juan Carlos, C/Gladiolo, s/n, 28933, Móstoles, Madrid, Spain;7. The Research Group in Gene - Environment and Health Interactions (GIIGAS), Biomedicine Institute (IBIOMED), University of León, Vegazana Campus, s/n, 24071, León, Spain;8. Oncology Data Analytics Program, Catalan Institute of Oncology (ICO), and ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via de l’Hospitalet, 199-203, 08908, L''Hospitalet de Llobregat, Barcelona, Spain;9. Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Gran Via de les Corts Catalanes, 585, 08007, Barcelona, Spain;10. Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, Gran Via de L''Hospitalet, 199-203, 08908, L’Hospitalet de Llobregat, Barcelona, Spain;11. Instituto de Salud Pública de Navarra, IdiSNA-Navarra Institute for Health Research, C/Leyre, 15, 31003, Pamplona, Navarra, Spain;12. University Institute of Oncology (IUOPA), University of Oviedo, Building "Santiago Gascón", 1st Floor. Campus of "El Cristo" B, 33006, Oviedo, Asturias, Spain;13. Department of Medical and Surgical Sciences, University of Cantabria - Marqués de Valdecilla Research Institute (IDIVAL), C/Cardenal Herrera Oria, s/n, 39011, Santander, Cantabria, Spain;14. Natural Resources, Health and Environment Research Center (RENSMA), University of Huelva, Avenida de las Fuerzas Armadas, s/n, 21007, Huelva, Spain;15. Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO), C/Micer Mascó, 31, 46010, Valencia, Spain;p. General Directorate Public Health, Valencian Community, Avenida de Cataluña, 21, 46020, Valencia, Spain;q. Preventive Medicine and Public Health Department, Faculty of Medicine, University of Granada, Avenida de la Investigación, 11, 18071, Granada, Spain;r. Granada Health Research Institute (ibs.GRANADA). Complejo Hospitalario Universitario de Granada, Avenida de las Fuerzas Armadas, 2, 18014, Granada, Spain;s. Department of Epidemiology, Murcia Health Authority, IMIB-Arrixaca, Ronda de Levante, 11, 30008, Murcia, Spain;t. Department of Health and Social Sciences, University of Murcia, Avenida Teniente Flomesta, 5, 30003, Murcia, Spain;u. Department of Oncology, Complejo Asistencial Universitario de León, Altos de Nava, s/n, 24071, León, Spain;v. Department of Gastroenterology, Hospital del Mar, Dr. Aiguader, 88, 08003, Barcelona, Spain;w. Hospital del Mar Medical Research Institute (IMIM), Dr. Aiguader, 88, 08003, Barcelona, Spain;x. ISGlobal, Doctor Aiguader, 88, 08003, Barcelona, Spain;y. Pompeu Fabra University (UPF), Plaça de la Mercè, 10-12, 08002, Barcelona, Spain;z. Spanish Network for Research in Infectious Diseases (REIPI), Avenida Dr. Fedriani, s/n, 41071, Sevilla, Spain;1. Univ. Bordeaux, Gironde General Cancer Registry, 33000, Bordeaux, France;2. Inserm, Bordeaux Population Health, Research Center U1219, Team Epicene, 33000, Bordeaux, France;3. Univ. Bordeaux, ISPED, 33000, Bordeaux, France;4. Medical Information Service, Public Health Department, Bordeaux University Hospital, 33000, Bordeaux, France;5. Gironde Screening Coordination Structure, 33700, Mérignac, France;6. Department of Medical Oncology, Institut Bergonié, 33000, Bordeaux, France;7. Clinical Investigation Center and Clinical Epidemiology, Inserm CIC1401, Institut Bergonié, 33000, Bordeaux, France;1. Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, 400 N. Ingalls, Ann Arbor, MI 48109, USA;2. Institute for Research on Women and Gender, University of Michigan, 204 S. State St., Ann Arbor, MI 48109, USA;3. College of Nursing, University of Illinois at Chicago, 845 S. Damen Avenue, Chicago, IL, 60612, USA;4. Department of Health Education and Promotion, College of Health and Human Performance, East Carolina University, 1000 East 5th Street, Greenville, NC, 27858, USA;5. Addiction Center, Department of Psychiatry, University of Michigan, Ann Arbor, MI 48109, USA;6. School of Nursing, Columbia University, 560 W. 168th Street, New York, NY, 10032, USA;7. Lung Care and Center for Tobacco-Free Living, St. Joseph Mercy Health System, 5333 McAuley Drive, RHB-4005, Ann Abor, MI 48197, USA;8. Institute for Healthcare Policy and Innovation, University of Michigan, 2800 Plymouth Road, North Campus Research Complex (NCRC), Building 16, Ann Arbor, MI 48109, USA;1. Department of Environment and Health, Istituto Superiore di Sanità, viale Regina Elena, 299 I-00161 Rome, Italy;2. Statistical Service, Istituto Superiore di Sanità, viale Regina Elena, 299 I-00161 Rome, Italy |
| |
| Abstract: | BackgroundThis study examined age distributions and age-specific incidence of screened cancers by Aboriginal status in New South Wales (NSW) to consider the appropriateness of screening target age ranges.MethodsThe NSW Cancer Registry identified invasive (female) breast, cervical and bowel cancers in people diagnosed in 2001–2014.ResultsAboriginal people were younger at diagnosis with higher proportions of breast and bowel cancers diagnosed before the screening target age range (<50 years) compared with non-Aboriginal people (30.6% vs. 22.8%, and 17.3% vs. 7.3%, respectively). Age-specific incidence rate ratios (IRRs) were lower/similar for breast and bowel cancers in younger and higher in older Aboriginal than non-Aboriginal people. All age-specific cervical cancer IRRs were higher for Aboriginal compared with non-Aboriginal people.ConclusionAlthough higher proportions of breast and colorectal cancers were diagnosed before screening commencement age in Aboriginal people, this does not necessarily indicate a need for earlier screening commencement. Other aspects needing consideration include benefits, harms and cost-effectiveness. |
| |
| Keywords: | Neoplasms Indigenous Australia Cancer screening Early detection of cancer |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
